関連する実験動画
Updated: Aug 1, 2026

08:51
A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
システィックフィブロシスに対するエアロゾールアルファ1-アンチトリプシン治療
N G McElvaney1, R C Hubbard, P Birrer
1Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.
Lancet (London, England)
|February 16, 1991
まとめ
空気中のアルファ1-アンチトリプシン (アルファ1AT) 治療は,システィック・フィブロシス患者における中性粒子の弾性酶を減少させた. この治療法により,保護酵素能力が回復し,バクテリアの殺戮が改善され,システィック線維症の宿主防御が強化されたことを示唆しています.
科学分野:
- 肺内医学 肺内医学 肺内医学
- 酵素阻害剤による治療法
- 胞性線維症の研究
背景:
- 胞性線維症は,呼吸道表面の中性粒子のエラスタゼによる慢性炎症を伴う.
- 中性粒子のエラスタゼは,呼吸器の表皮を負担する破壊的な酵素です.
- アルファ1-アンチトリプシン (アルファ1AT) は,肺における中性粒子の弾性酶の主な阻害剤である.
研究 の 目的:
- 軟骨性線維症患者における空気溶融アルファ1抗トリプシン (アルファ1AT) の有効性を調査する.
- 呼吸器内皮質内膜液 (ELF) の中性粒子のエラスタゼレベルに対するアルファ1ATの影響を評価する.
- アルファ1AT治療により,抗中性粒子の弾性酵素能力が回復し,宿主の防御を改善できるかどうかを判断する.
主な方法:
- アエロゾー化アルファ1-アンチトリプシン (アルファ1AT) は,システィックフィブロシス患者12人に投与されました.
- ELFにおける中性粒子のエラスタゼとアルファ1AT濃度の測定が行われました.
- 中性粒子の媒介によるPseudomonas殺菌に対するシスティック線維症ELFの効果は,治療前のおよび後の評価された.
主要な成果:
- エアロゾー化アルファ1ATは,呼吸器内皮質内膜液 (ELF) の中性粒子のエラスタゼを抑制した.
- ELFα1ATが8mmol/lに達したとき,ELFの抗中性粒子の弾性酵素能力が回復した.
- 中性粒子が殺すPseudomonasに対するシスティック線維症ELFの抑制効果は逆転した.
結論:
- 空気中のアルファ1-アンチトリプシン (α1-antitrypsin) は,システィック線維症における中性粒子のエラスターゼの管理に有効です.
- ELFの抗中性粒子のエラスタゼ能力の回復は,潜在的な治療効果を示唆しています.
- この治療は,システィック線維症患者の宿主防衛機構を強化し,Pseudomonasの殺戮能力を向上させる可能性があります.
関連する概念動画
Breathing
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chest Physiotherapy
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

